Macsart H Tablet is a combination antihypertensive medication containing Telmisartan 40 mg and Hydrochlorothiazide 12.5 mg. Telmisartan is an angiotensin II receptor blocker (ARB) that selectively inhibits the binding of angiotensin II to the AT1 receptor, thereby reducing vasoconstriction and aldosterone secretion, which leads to decreased blood pressure. Hydrochlorothiazide is a thiazide diuretic that promotes the excretion of sodium and water by inhibiting sodium reabsorption in the distal convoluted tubules of the kidneys, resulting in reduced plasma volume and peripheral resistance. The combination of these two agents provides complementary mechanisms to effectively control hypertension, especially in patients who require more than one agent to achieve target blood pressure. Macsart H is indicated for the treatment of essential hypertension and may be used when monotherapy with either component is insufficient. The medication should be used with caution in patients with renal or hepatic impairment, electrolyte imbalances, or a history of hypersensitivity to sulfonamides. Common side effects include dizziness, hypotension, electrolyte disturbances, and increased urination. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy. Macsart H Tablet should be taken as prescribed by a healthcare professional to optimize therapeutic outcomes and minimize adverse effects.